Alamar Biosciences, Inc. ALMR
$20.13
▼ -0.86% 24H
About
Alamar Biosciences, Inc. is a commercial-stage proteomics company specializing in advanced protein detection and analysis technologies. It develops and commercializes the proprietary NULISA platform, designed to overcome limitations of traditional proteomics tools by enabling detection of protein biomarkers at extremel…
SectorHealthcare
ExchangeNASDAQ
IndustryMedical Devices
CountryUnited States
Employees222
TickerALMR
Statistics
Market Cap$1.34B
Revenue (TTM)$74.2M
Net Income-$29.8M
Net Margin-40.2%
EPS$-0.45
P/E-49.50
P/S17.65
P/B-8.09
EV/EBITDA-56.54
ROE18.8%
Dividend Yield—
Price$20.13
Data: Twelve Data · Revenue = mcap / P/S